tiprankstipranks
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
HKEX:8189
Hong Kong Market
8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
RESEARCH TOOLSreports

Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) Stock Price & Analysis

0 Followers

8189 Stock Chart & Stats

Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.06 - HK$0.10
Previous CloseHK$0.08
Volume1.58M
Average Volume (3M)156.84K
Market Cap
HK$153.49M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)
Beta-0.17
Nov 11, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,197,000,000
10 Day Avg. Volume14,000
30 Day Avg. Volume156,842
Standard Deviation0.17
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

8189 FAQ

What was Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H lowest stock price was HK$0.06 and its highest was HK$0.10 in the past 12 months.
    What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap?
    Currently, no data Available
    When is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date?
    Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date is Nov 11, 2024 which is in 115 days.
      How were Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s earnings last quarter?
      Currently, no data Available
      Is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H overvalued?
      According to Wall Street analysts Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H pay dividends?
        Tianjin TEDA Biomedical Engineering Co. Ltd. Class H does not currently pay dividends.
        What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate?
        Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H have?
        Tianjin TEDA Biomedical Engineering Co. Ltd. Class H has 1,196,999,900 shares outstanding.
          What happened to Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Tianjin TEDA Biomedical Engineering Co. Ltd. Class H?
          Currently, no hedge funds are holding shares in HK:8189
          ---

          Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          24.61%
          12-Months-Change

          Fundamentals

          Return on Equity
          -23.86%
          Trailing 12-Months
          Asset Growth
          -11.80%
          Trailing 12-Months
          Similar Stocks
          Company
          Price & Change
          Follow
          Beijing Health (Holdings) Limited
          China Chuanglian Education Financial Group Limi ted
          Charmacy Pharmaceutical Co., Ltd. Class H
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis